|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3389712 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16831788.1 |
| Europos patento paraiškos padavimo data | 2016-12-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-04-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/067200 |
| Data | 2016-12-16 |
| (87) | Numeris | WO 2017/106656 |
| Data | 2017-06-22 |
| (30) | Numeris | Data | Šalis |
| 201562269044 P | 2015-12-17 | US | |
| 201662331371 P | 2016-05-03 | US | |
| 201662344784 P | 2016-06-02 | US | |
| 201662347331 P | 2016-06-08 | US | |
| 201662359781 P | 2016-07-08 | US | |
| 201662381384 P | 2016-08-30 | US | |
| 201662400787 P | 2016-09-28 | US | |
| 201662414128 P | 2016-10-28 | US | |
| 201662431846 P | 2016-12-09 | US |
| (72) |
BILIC, Sanela , US
HOWARD, Danny, Roland, Jr. , US
CAMERON, John, Scott , US
DRANOFF, Glenn , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ANTIBODY MOLECULES TO PD-1 AND USES THEREOF |
| ANTIBODY MOLECULES TO PD-1 AND USES THEREOF |